Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling.

MLA

Ortiz-Vilchis, Pilar, et al. “Co-Administration of the Flavanol (-)-Epicatechin with Doxycycline Synergistically Reduces Infarct Size in a Model of Ischemia Reperfusion Injury by Inhibition of Mitochondrial Swelling.” European Journal of Pharmacology, vol. 744, Dec. 2014, pp. 76–82. EBSCOhost, https://doi.org/10.1016/j.ejphar.2014.09.042.

APA

Ortiz-Vilchis, P., Yamazaki, K. G., Rubio-Gayosso, I., Ramirez-Sanchez, I., Calzada, C., Romero-Perez, D., Ortiz, A., Meaney, E., Taub, P., Villarreal, F., & Ceballos, G. (2014). Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling. European Journal of Pharmacology, 744, 76–82. https://doi.org/10.1016/j.ejphar.2014.09.042

Chicago

Ortiz-Vilchis, Pilar, Katrina Go Yamazaki, Ivan Rubio-Gayosso, Israel Ramirez-Sanchez, Claudia Calzada, Diego Romero-Perez, Alicia Ortiz, et al. 2014. “Co-Administration of the Flavanol (-)-Epicatechin with Doxycycline Synergistically Reduces Infarct Size in a Model of Ischemia Reperfusion Injury by Inhibition of Mitochondrial Swelling.” European Journal of Pharmacology 744 (December): 76–82. doi:10.1016/j.ejphar.2014.09.042.